郭名南

Bone health trajectories following regimen optimization in male people living with HIV receiving TDF: a prospective, observational, cohort study

TDF exposure is associated with reduced bone mineral density (BMD) in people living with HIV (PLWH). Data remain limited evaluating changes in BMD and bone turnover markers (BTMs) after switching to tenofovir alafenamide (TAF), TDF/TAF-free regimens such as dolutegravir/lamivudin...